MileCell Biotechnology is pleased to announce its participation in the BIO International Convention 2026, taking place June 22–25 in San Diego, California. As one of the world’s premier biotechnology partnering events, BIO International Convention brings together biotechnology innovators, pharmaceutical companies, investors, service providers, and research organizations from around the globe. The event provides a unique […]
San Diego, CA — June 2026 MileCell Biotechnology is pleased to announce its membership in the 3Rs Collaborative (3RsC), a nonprofit organization dedicated to advancing better science for both people and animals through the principles of Refinement, Reduction, and Replacement (3Rs). The 3Rs Collaborative brings together stakeholders from industry, academia, government, and regulatory agencies to accelerate the […]
MileCell Biotechnology is pleased to announce its participation in the 2026 European ISSX Meeting, taking place June 29 – July 2, 2026. As one of the leading international conferences dedicated to drug metabolism, pharmacokinetics, and translational ADME sciences, ISSX Europe brings together researchers, scientists, and industry professionals focused on advancing more predictive and biologically relevant […]
MileCell Biotechnology is pleased to announce our participation in The 53rd Annual Meeting of the Japanese Society of Toxicology (JSOT 2026), taking place from July 1–3, 2026, at the Osaka International Convention Center, Japan. As one of Japan’s leading meetings in toxicology and safety sciences, JSOT provides an important platform for researchers, industry professionals, and […]
MileCell is pleased to introduce a side-by-side comparison of Kryogene Cell Freezing Media, designed to help researchers identify the most suitable cryopreservation solution for different cell types, research applications, and workflow requirements. Cryopreservation is an essential step in maintaining cell viability, consistency, and post-thaw performance. However, different research workflows may require different formulation features, including […]
Boston, MA — May 2026 — MileCell Bio, a provider of high-quality primary cell–based solutions for life science research, today announced that it will exhibit at the ASGCT 2026 Annual Meeting, taking place May 12–14, 2026, in Boston, Massachusetts. Attendees are invited to visit Booth #1162 to explore MileCell’s portfolio of CGT-ready primary cells and reagents, designed to support […]
Advancing Hepatic ADME with Predictive In Vitro Models MileCell is pleased to announce its participation as a Bronze Sponsor at the 2026 Great Lakes Drug Metabolism & Disposition Group (GLDMDG) Meeting, taking place May 7–8, 2026, at the Chicago Botanic Garden in Glencoe, Illinois. The GLDMDG meeting brings together scientists from pharmaceutical companies, biotechnology firms, and academic institutions to facilitate […]
MileCell Bio will exhibit at the AACR Annual Meeting 2026, taking place April 17–22, 2026, at the San Diego Convention Center in San Diego, California. As the premier global gathering in oncology, AACR brings together researchers and industry leaders across cancer biology, translational science, and clinical development to advance breakthroughs that improve patient outcomes. Aligned […]
MileCell Bio will exhibit at the 2026 Annual Meeting of the Society of Toxicology (SOT) and ToxExpo, taking place March 22–25, 2026, at the San Diego Convention Center in San Diego, California. As one of the most influential global meetings in toxicology and safety science, SOT brings together experts in drug metabolism, preclinical safety evaluation, […]
